Home > Insider Trading > Filing (0001209191-21-063217)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1408500	E Martin Cearnal	2525 West End Ave. Suite 950 Nashville TN 37203	Sr Vp/Chief Commercial Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-10-01	105	$2.69	171,774	No	4	P	Direct
Common Stock	Acquisiton	2021-10-04	105	$2.87	171,879	No	4	P	Direct
Common Stock	Acquisiton	2021-10-05	105	$2.82	171,984	No	4	P	Direct
Common Stock	Acquisiton	2021-10-06	105	$2.76	172,089	No	4	P	Direct
Common Stock	Acquisiton	2021-10-07	105	$2.76	172,194	No	4	P	Direct
Common Stock	Acquisiton	2021-10-08	105	$2.84	172,299	No	4	P	Direct
Common Stock	Acquisiton	2021-10-11	105	$2.73	172,404	No	4	P	Direct
Common Stock	Acquisiton	2021-10-12	105	$2.71	172,509	No	4	P	Direct
Common Stock	Acquisiton	2021-10-13	105	$2.71	172,614	No	4	P	Direct
Common Stock	Acquisiton	2021-10-14	105	$2.81	172,719	No	4	P	Direct
Common Stock	Acquisiton	2021-10-15	105	$2.76	172,824	No	4	P	Direct
Common Stock	Acquisiton	2021-10-18	105	$2.75	172,929	No	4	P	Direct
Common Stock	Acquisiton	2021-10-19	105	$2.76	173,034	No	4	P	Direct
Common Stock	Acquisiton	2021-10-20	105	$2.63	173,139	No	4	P	Direct
Common Stock	Acquisiton	2021-10-21	105	$2.65	173,244	No	4	P	Direct
Common Stock	Acquisiton	2021-10-22	105	$2.66	173,349	No	4	P	Direct
Common Stock	Acquisiton	2021-10-25	105	$2.64	173,454	No	4	P	Direct
Common Stock	Acquisiton	2021-10-26	105	$2.64	173,559	No	4	P	Direct
Common Stock	Acquisiton	2021-10-27	105	$2.61	173,664	No	4	P	Direct
Common Stock	Acquisiton	2021-10-28	105	$2.61	173,769	No	4	P	Direct
Common Stock	Acquisiton	2021-10-29	105	$2.72	173,874	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2021.